Clinical Trial

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

Study acronym: BIOMOHS
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standard of sare versus standard of sare slone in the management of post-mohs micrographic surgery defects.
Trial Details
NCT Number NCT07695389
Lead Sponsor BioLab Holdings
Collaborators: SerenaGroup, Inc.
Conditions Undergone Mohs Micrographic Surgery, Cutaneous Malignancy, Mohs Surgical Defect
Enrollment 160 participants
Start Date 2026-07-01
Primary Completion 2028-07-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-10